Top Tangential Flow Filtration Companies

As a result of its advantages and swift adoption by bio-manufacturers, the industry has been expanding without end for the past few years. Key companies in the TFF market now have worthwhile chances thanks to the rising application in domains like immunology, microbiology, and protein purification procedures. A large product line of filtering products for a variety of applications has also led to considerable income generating. Players use a variety of strategic efforts, including alliances, acquisitions, new product launches, and collaborations, to achieve a competitive advantage.

For instance, Solaris Biotechnology Srl, a producer of bioprocessing equipment with headquarters in Italy, was purchased by Donaldson Company, Inc. in 2021 for USD 40.3 million (EUR 41 million). Since Solaris's portfolio comprised bioreactors, TFF structures, and fermenters, the acquisition increased the company's access to clients in the biopharmaceutical and life science industries. These business initiatives will expand the product line, increase the use of TFF goods in bioprocessing operations, or raise market rivalry, all of which will move the market forward.

Tangential Flow Filtration Market Top Player’s Company Profiles

• Merck KGaA

• Sartorius AG

• GE Healthcare

• Thermo Fisher Scientific Inc.

• Danaher Corporation

• MilliporeSigma

• Repligen Corporation

• 3M Company

• Pall Corporation (a division of Danaher Corporation)

• Parker Hannifin Corporation

• Asahi Kasei Corporation

• Alfa Laval AB

• Eppendorf AG

• Spectrum Laboratories, Inc. (a subsidiary of Repligen Corporation)

• Cole-Parmer Instrument Company LLC

• GEA Group AG

• Novasep Holding S.A.S.

• Filtration Group Corporation

• Starlab Scientific Co., Ltd.

• Alfa Wassermann Separation Technologies S.p.A.